Protagenic Therapeutics Files 2024 10-K
Ticker: PTIXW · Form: 10-K · Filed: Mar 31, 2025 · CIK: 1022899
| Field | Detail |
|---|---|
| Company | Protagenic Therapeutics, Inc.\New (PTIXW) |
| Form Type | 10-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, pharmaceuticals, financials
Related Tickers: PTIX
TL;DR
Protagenic Therapeutics filed its 2024 10-K. Check financials.
AI Summary
Protagenic Therapeutics, Inc. filed its 10-K for the fiscal year ending December 31, 2024. The company, formerly known as Atrinsic, Inc., MPLC, Inc., and NEW MOTION, INC., is based in New York and operates in the Pharmaceutical Preparations sector. The filing covers the period from January 1, 2024, to December 31, 2024, and was submitted on March 31, 2025.
Why It Matters
This 10-K filing provides a comprehensive overview of Protagenic Therapeutics' financial performance and business operations for the fiscal year 2024, crucial for investors assessing the company's health and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Protagenic Therapeutics is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2025-03-31 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- Protagenic Therapeutics, Inc. (company) — Filer
- Atrinsic, Inc. (company) — Former company name
- NEW MOTION, INC. (company) — Former company name
- MPLC, Inc. (company) — Former company name
- 2024-12-31 (date) — Fiscal year end
- 2025-03-31 (date) — Filing date
- 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY 10010 (address) — Business and Mail Address
FAQ
What is the primary business of Protagenic Therapeutics, Inc.?
Protagenic Therapeutics, Inc. operates in the Pharmaceutical Preparations sector, as indicated by its Standard Industrial Classification code [2834].
When did Protagenic Therapeutics, Inc. change its name from Atrinsic, Inc.?
The company's name was changed from Atrinsic, Inc. on June 30, 2009.
What is the SEC file number for Protagenic Therapeutics, Inc.'s 10-K filing?
The SEC file number for this filing is 001-12555.
What is the business address of Protagenic Therapeutics, Inc.?
The business address is 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY 10010.
What fiscal year does this 10-K filing cover?
This 10-K filing covers the fiscal year ending December 31, 2024.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding Protagenic Therapeutics, Inc.\new (PTIXW).